Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia
December 1, 2025 |
For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.
Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come.
Among the proven benefits of Medscape AI:
- Reliability: Clinically Vetted Sources, Transparent By Design
- Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
- AI responses are traceable, transparent, and supported by citations
- Recency: Always Current and Continuously Updated
- Integrates verified real-time news, research updates, and guideline changes
- Daily and weekly editorial oversight ensures outputs reflect the latest evidence
- Relevance: Aligned to Practice and Patient Care
- Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
- Synthesized insights tuned to each specialty, workflow, and clinical context
- Guidance supports differential diagnosis, treatment decisions, and next-step care
- Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools
- Time-Saving Clinical Efficiency
- Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature
“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”
Medscape is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month.
Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!
Educational Symposia
Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.
- Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
- Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
- Time: 11:30 AM – 1:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International DEFG
- Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
- Time: 11:30 AM – 1:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
- Time: 3:30 PM – 5:00 PM ET
- Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
- Room: W311 EFGH
- Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
- Time: 3:30 PM – 5:00 PM ET
- Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
- Room: Plaza International HIJK
ASH Abstract Publication
Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood.
For more information, please contact Jelena Spyropoulos.
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
Hear From Her: Extraordinary Women Who Are Redefining Healthcare Leadership
That’s a wrap for Season 2 of Medscape Education’s Award-Winning Podcast Series, Hear From Her: Women in Healthcare Leadership! (Not to worry, Season 3 is just around the corner.) And...
Bringing Clinicians Together for Oncology Education at ESMO 2024
ESMO 2024 comes with the debut of 2 new, exciting symposia hosted by the MedscapeLIVE! team. The symposia build on nearly 30 years of Medscape’s experience and excellence in both...
Empowering Women in Health Care Through Education
In a bold stride toward empowering women in health care, Medscape proudly announces its sponsorship of the highly anticipated Women in Medicine Summit, September 13-14, 2024 in Chicago, Illinois. This...
Leading the Way at ESC 2024
Anticipation is building at Medscape Education as the team prepares for the ESC 2024 Congress. We are excited to announce a significant presence during the congress including a booth (#H500)...
Always Be in a Growth Mindset: Chief Strategy Officer Christina Hoffman’s Return to Her Education Roots
Medicine is always changing, and the career of Medscape Education’s Chief Strategy Officer, Christina Hoffman, is no exception. The 17-year Medscape veteran recently said goodbye to her role as leader...
Medscape Education Showcases Unprecedented Achievements at EHA 2024
Medscape Education is proud to share its monumental success at the EHA 2024 Congress. Our continued commitment to patient-centric medical education was evident throughout the event, with notable achievements and...
Reaching Women Where They’re At: Setting Up a Safe Space for HIV Prevention Conversations
“I always enjoyed solving problems and putting puzzles together,” says Harmony Garges, MD, CMO at ViiV Healthcare and a pediatric infectious disease specialist. “So for me, infectious disease was a...
Medscape Education Demonstrates Strong Education Outcomes at the American Diabetes Association 2024 Conference
Medscape Education presented seven scientific posters at this year’s American Diabetes Association (ADA) conference in Orlando, Florida. These posters highlighted the outcomes of Medscape Education’s continuing medical education programs, which...
Stemming the Flow–Medscape Presents at HLTH Europe
Medscape Education will be attending HLTH Europe from June 17-20. Be sure to drop by our booth to participate in our survey and enjoy exciting giveaways. Additionally, Dr. John Whyte,...
Medscape Education to Emphasize the Role of Education in Digital Therapeutics at DTA Summit
As a leader in medical education and proud sponsor of the 2024 Digital Therapeutics Summit, Medscape is excited to announce that Medscape Education’s Chief Strategy Officer, Christina Hoffman, will be...